BioRestorative Therapies, Inc. , a life sciences company focused on adult stem cell-based therapies for various personal medical applications, announces the engagement of Access BIO, L.C. to provide strategic preclinical and regulatory consulting services related to the Company's brtxDISCa program. Initially Access BIO will help the Company prepare for pre-Investigational New Drug and IND meetings with the U.S. Food and Drug Administration .
http://ift.tt/1w1zJzj
http://ift.tt/1w1zJzj
No comments:
Post a Comment